| Haven Of Lakeside | |
| 3401 North Lockwood Drive, Lakeside, Arizona 85929 | |
| (928) 368-2060 | |
| Name | Haven Of Lakeside |
|---|---|
| Location | 3401 North Lockwood Drive, Lakeside, Arizona |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 112 |
| Occupancy Rate | 55.54% |
| Medicare ID (CCN) | 035277 |
| Legal Business Name | Haven Of Lakeside Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1073894598 |
| Organization Name | LWN MEDICAL PLLC |
| Address | 3401 Lockwood Dr, Lakeside, AZ 85929 |
| Phone Number | 928-368-2060 |
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago
| NPI Number | 1447657994 |
| Organization Name | HAVEN HEALTH LAKESIDE |
| Doing Business As | HAVEN HEALTH LAKESIDE |
| Address | 3401 Lockwood Dr, Lakeside, AZ 85929 |
| Phone Number | 801-296-5100 |
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago
| NPI Number | 1568882991 |
| Organization Name | SIERRA BLANCA REHABILITATION LLC |
| Address | 3401 Lockwood Dr, Lakeside, AZ 85929 |
| Phone Number | 928-368-2060 |
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago
| NPI Number | 1760701221 |
| Organization Name | SIERRA BLANCA REHABILITATION LLC |
| Address | 3401 N Lockwood Dr, Lakeside, AZ 85929 |
| Phone Number | 928-368-2060 |
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.1 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.34 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.03 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.35 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.21 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.63 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.86 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 89.84 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.23 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.03 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.42 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 23.14 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.48 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.74 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.83 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 55.04 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.83 | 82.93 |
News Archive
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.
A new study by researchers at the City University of Hong Kong examined the efficacy of non-pharmaceutical interventions (NPIs) on controlling the coronavirus disease 2019 (COVID-19) pandemic, the illness SARS-CoV-2 causes.
Progressive degeneration of photoreceptors-the rods and cones of the eyes-causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors. As described in a study appearing in the February 19 issue of the Cell Press journal Neuron, the compound may be a potential drug candidate for treating patients suffering from degenerative retinal disorders.
› Verified 4 days ago